Pharmaceutical Filtration Devices Market report, published by Market Research Future contains succinct information on to provide country level analysis of the market with respect to the current market size and future prospective for segments by type, by application, by end user and its sub-segments.
Pune, Maharashtra – April 17, 2019 /MarketersMedia/ —
Filtration is used in pharmaceutical industry to purify and separate the component of therapeutic application. Additionally, the process can be used to maintain sterile conditions of processing and prevent contamination of the therapeutic entities. Various methods of filtration like air filtration, water filtration, chemical filtrations, grade filtration are being used for filtration in the pharmaceutical industry. Factors such as growing biotechnology and pharmaceutical sector and rising healthcare expenditure are the major drivers for the market growth during the forecast period.
The U.S. is the largest market for biopharmaceuticals and accounts for one third of the global market. Moreover, it is estimated that the U.S. biopharmaceutical sector accounts for around 17% of all domestic R&D funded by the U.S. businesses and added an estimated USD 1.2 trillion in economic output of 2014. Additionally, rising global burden of the diseases and increasing demands for healthcare services boosts the market. However, huge capital cost for setting up new production facilities followed by stringent government regulations are estimated to restrain the market growth during the forecast period.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2432
Pharmaceutical Filtrations Devices Market – Key Players
Some of the key players in this market are:
GE Healthcare (U.S.)
Pall Corporation (U.S.)
Parker Hannifin Corporation (U.S.)
Sartorius Stedim Biotech S.A. (France)
Merck KGaA (Germany)
Alfa Laval (Sweden)
Graver Technologies, LLC (U.S.)
Koch Membrane Systems Inc. (U.S.)
GEA Group (Germany)
Pharmaceutical Filtrations Devices Market – Segments
The pharmaceutical filtrations market has been segmented on the basis of type of filtrations, product, and their application in pharmaceutical industry. On the basis of type the market has been segmented as air filtration, water filtration, chemical filtrations, Grade filtration (liquid and gas), and absorptive filtrations. Similarly, on the basis of product, the market has been segmented into membrane filters, media filters, cartridges and capsule filtration and others. On the basis of application in pharmaceutical industry the filtrations market has again segment into air purification, water purification, sterilization, cell separation, media and buffer filtrations and others.
Pharmaceutical Filtrations Devices Market – Regional Analysis
The Americas holds the largest market share owing to a well-developed pharmaceutical sector and increasing healthcare expenditure. Following the similar trends Europe stands second in the global market. On regional basis Europe is divided into Western Europe and Eastern Europe. Western Europe leads the market due to the presence of the developed economies like Germany, Italy, France, and others. Asia Pacific is the fastest growing region in the market. On the other hand, the Middle East & Africa holds the least market share, mainly due to the presence of low-income countries within the African region.
Pharmaceutical Filtration Devices Market – Competitive Analysis
In February 2017- Parker Hannifin Corporation, completed the acquisition of CLARCOR Inc., a major manufacturer of filtration products, for approximately USD 4.3 billion in cash which included the assumption of net debt. The strategic transaction created a combined organization with a comprehensive portfolio of filtration products and technologies, offering customers a single streamlined source for all their purification and separation needs.
In April 2017- Sartorius Stedim Biotech acquired the Umetrics business (from the U.S. based MKS Instruments Group. Umetrics is a highly specialized, globally leading provider of data analytics software for modelling and optimizing development and manufacturing processes. SSB has been a cooperation partner of Umetrics since the end of 2012, distributing and co-marketing their software to major players in the biopharmaceutical industry.
In September 2016- GE Healthcare acquired Biosafe Group and introduced Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing and final formulation during cell processing. Combined with GE Healthcare’s existing portfolio, Sefia further advances access to a single-solution manufacturing platform to enable turnkey, scalable manufacturing of cell therapies.
In May 2015- Danaher Corporation announced today that the company entered into a definitive merger agreement with Pall Corporation pursuant to which Danaher acquired all of the outstanding shares of Pall for USD 127.20 per share in cash, i.e., for a total enterprise value of approximately USD 13.8 billion, including assumed debt and net of acquired cash.
Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/pharmaceutical-filtration-devices-market-2432
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Release ID: 503721